JPRN-jRCT2080223511已完成3 期
A Phase III, multicenter, randomized, double-blind, placebo controlled, parallel group study to assess the efficacy and safety of KRP-116D in Japanese patients with interstitial cystisis.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 109
研究概览
简要总结
Efficacy of the KRP-116D compared with placebo was evaluated
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Diagnosed with IC
排除标准
- •Patients has complication or past history within 5 years with cancer
- •Patients complicated with urinary tract/genital infection
- •Patients has past history with augmentation cystoplasty or cystectomy
研究者
相似试验
已完成
3 期
Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)Chronic Hepatitis BHepatitis B, ChronicNCT05630807GlaxoSmithKline981
已完成
3 期
Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)Chronic Hepatitis BHepatitis B, ChronicNCT05630820GlaxoSmithKline857
已完成
3 期
Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 TabletHypertensive Patients With DyslipidemiaNCT03583905Chong Kun Dang Pharmaceutical154
已完成
2 期
A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)SCDNCT01384435Kissei Pharmaceutical Co., Ltd.200
Unknown
3 期
Efficacy Study to Treat Subjects With Severe HypertriglyceridemiaSevere HypertriglyceridemiaNCT01229566Trygg Pharma, Inc.240